Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Abroad (travel likely)RecruitingPHASE1
Conditions
Lung Cancer Metastatic · EGFR Gene Mutation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Collin Blakely, MD, PhD)
Study leads
Collin Blakely, MD, PhD
Principal Investigator
University of California, San Francisco